Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
Launched by SOLVAY PHARMACEUTICALS · Sep 8, 2005
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • essential hypertension,
- • diabetes type 2
- Exclusion Criteria:
- • severe cardiovascular disease,
- • grade 3 hypertension,
- • secondary hypertension,
- • abnormal liver enzymes
About Solvay Pharmaceuticals
Solvay Pharmaceuticals is a global biopharmaceutical company dedicated to improving patient health through innovative research and development. As a subsidiary of Solvay, a multinational chemical and advanced materials company, Solvay Pharmaceuticals focuses on delivering transformative therapies across various therapeutic areas, including central nervous system disorders, cardiovascular health, and women's health. Committed to scientific excellence and patient-centric solutions, the company collaborates with healthcare professionals and regulatory bodies to advance clinical trials and bring safe, effective medications to market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, , Canada
Montreal, , Canada
Quebec, , Canada
Thornhill, , Canada
Vancouver, , Canada
Winnipeg, , Canada
Holbaek, , Denmark
Roskilde, , Denmark
Viborg, , Denmark
Anzin, , France
Blois, , France
Chemellier, , France
Cholet, , France
Cholet, , France
Cholet, , France
La Jubaudiere, , France
Le Mesnil En Vallee, , France
Murs Erigne, , France
Saumur, , France
Segre, , France
St Pierre Montlim, , France
Thouars, , France
Tours, , France
Vieux Conde, , France
Bad Muenster, , Germany
Floersheim, , Germany
Kirweiler, , Germany
Lambrecht, , Germany
Lindau, , Germany
Lueneburg, , Germany
Lutherstadt, , Germany
Riesa, , Germany
Waldbrunn, , Germany
Bologna, , Italy
Napoli, , Italy
Padova, , Italy
Palermo, , Italy
Pavia, , Italy
Pisa, , Italy
Torino, , Italy
Alesund, , Norway
Bergen, , Norway
Horten, , Norway
Skedsmokorset, , Norway
Badajoz, , Spain
Badalona, , Spain
Barcelona, , Spain
Barcelona, , Spain
Ciudad Real, , Spain
Granada, , Spain
Madrid, , Spain
Angelholm, , Sweden
Goteburg, , Sweden
Helsingborg, , Sweden
Kristianstat, , Sweden
Malmo, , Sweden
Stockholm, , Sweden
Aberdeen, , United Kingdom
Bath, , United Kingdom
Liverpool, , United Kingdom
Manchester, , United Kingdom
Oldham, , United Kingdom
Rugby, , United Kingdom
Patients applied
Trial Officials
Global Clinical Director Solvay
Study Director
Solvay Pharmaceuticals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials